3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
44
Lung Neoplasms
24
Neoplasms
7
Neoplasm Metastasis
6
Colorectal Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Pancreatic Neoplasms
4
Mesothelioma, Malignant
3
Colonic Neoplasms
3
Rectal Neoplasms
2
Ovarian Neoplasms
2
Non-squamous Non-small Cell Lung Cancer
2
Neoplasms by Site
2
Melanoma
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma
2
Adenocarcinoma of Lung
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Salivary Gland Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Resectable Non-small Cell Lung Cancer
1
Interventions
Rituximab
15
Cyclophosphamide
15
Prednisone
11
Doxorubicin
10
Vincristine
7
Lenalidomide
7
ibrutinib
6
polatuzumab vedotin
4
obinutuzumab
4
glofitamab
4
fludarabine
4
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
venetoclax
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Specimen Handling
3
R-CHOP protocol
3
Etoposide
3
Cyclosporine
3
Biopsy
3
zanubrutinib
2
prednylidene
2
pembrolizumab
2
deltacortene
2
acalabrutinib
2
Prednisolone
2
Mycophenolic Acid
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
Pemetrexed
×
30 days
×
Clear all
No trials found.